$93.30+14.70% · 3M
Moving avg
1W+3.99%
1M+6.91%
3M+14.65%
6M+22.97%
YTD+9.34%
1Y+19.34%
3Y+15.86%
5Y-18.42%
52-week range
$72.3088% of range$96.29
Company health
Value0/6
Growth3/6
Profitability5/6
Health5/6
Dividend0/6
Bull vs bear
Strengths
- Analyst consensus is "Buy"
- High return on equity (971%)
- Net cash on the balance sheet
Risks
- Richly valued at 47.5x earnings
Key statistics
Valuation
Market cap
$53.72B
Enterprise value
$45.83B
P/E ratio (TTM)
47.49x
P/S ratio (TTM)
7.31x
EV/EBITDA
29.76x
Per share & returns
EPS (TTM)
$1.74
Dividend yield
0.00%
Beta (1Y)
0.85
30-day change
+6.91%
Trading
Volume (24h)
374.75K
Previous close
$93.05
Shares outstanding
575.80M
About Edwards Lifesciences Corporation
Sector
Healthcare
Industry
Medical - Devices
Exchange
NYSE
Symbol
EW
Edwards Lifesciences Corporation is a large-cap healthcare company in the Medical - Devices industry. Its shares are listed on NYSE (United States) and trade under the ticker EW.
Frequently asked questions
What is Edwards Lifesciences Corporation's market cap?
Edwards Lifesciences Corporation (EW) has a market capitalization of $53.72B.
What is Edwards Lifesciences Corporation's P/E ratio?
Edwards Lifesciences Corporation trades at a price-to-earnings (P/E) ratio of 47.49.
What exchange does EW trade on?
EW trades on NYSE.
Appears in
Eli Lilly and CompanyLLY
$1,220.02-0.02%
$1.15T cap
Johnson & JohnsonJNJ
$261.21+0.13%
$629.49B cap
AbbVie Inc.ABBV
$250.31+0.62%
$442.25B cap
UnitedHealth Group IncorporatedUNH
$403.33-0.56%
$366.28B cap
Roche Holding AGSWX: ROP
CHF 362.30-0.88%
$355.30B cap
Merck & Co., Inc.MRK
$134.58+1.25%
$332.39B cap
Novartis AGSWX: NOVN
CHF 123.96-0.19%
$290.28B cap
AstraZeneca PLCLON: AZN
£117.08+0.05%
$245.27B cap